No Benefit of Rituximab in Primary Central Nervous System Lymphoma Patients: Results of the Randomised Phase III HOVON 105 / ALLG NHL 24 Intergroup StudyRituximabPCNSLPrimary Central Nervous System Lymphoma treatmentBackground: Efficacy of rituximab in Primary Central Nervous System Lymphoma (PCNSL) is ...